ORAL DOSAGE FORMS COMPRISING 3-PYRIDYL-1-HYDROXY-ETHYLIDENE-1,1-BISPHOSPHONIC ACID (RISEDRONATE) AND HAVING AN ENTERIC COATING TO DELAY RELEASE UNTIL THE LOWER INTESTINAL TRACT

The present invention is directed to a novel enteric-coated oral dosage form of a risedronate active ingredient comprised of a safe and effective amount of a pharmaceutical composition which is comprised of a risedronate active ingredient and pharmaceutically-acceptable excipients. Said dosage forms...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	MOSHER R Y, AXELROD D W, SIETSEMA W K, DANSEREAU R J
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!